Tapinarof Cream, 1%
Tapinarof Cream, 1% is a pharmaceutical drug with 10 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
2
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis.
Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis
Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis
Clinical Trials (10)
A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis.
Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis
Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)
Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis
Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)
Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10